Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Cardiology. Cardiovascular Risk and Prevention|June 12, 2025
Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudyTania Sharma, Akiko Maehara, Michael Maeng, et al.
Circulation. Cardiovascular Interventions|September 25, 2024
Impact of Lipidic Plaque on In-Stent and Stent Edge-Related Events After PCI in Myocardial Infarction: A PROSPECT II SubstudyLars Kjøller-Hansen, Akiko Maehara, Henning Kelbæk, et al.
Clinical Chemistry|May 14, 2026
Exploring Sex-Specific High-Sensitivity Cardiac Troponin Thresholds for Rule-Out of Non-ST-Elevation Myocardial InfarctionIngar Ziad Restan, Yong Yong Tew, Ole-Thomas Steiro, et al.
BMJ Open|February 15, 2020
Rethinking rehabilitation after percutaneous coronary intervention: a protocol of a multicentre cohort study on continuity of care, health literacy, adherence and costs at all care levels (the CONCARDPCI)Tone M Norekvål, Heather G Allore, Bjørn Bendz, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|November 30, 2016
A statistical analysis protocol for the time-differentiated target temperature management after out-of-hospital cardiac arrest (TTH48) clinical trialHans Kirkegaard, Asger Roer Pedersen, Ville Pettilä, et al.
European Heart Journal. Acute Cardiovascular Care|January 13, 2022
Adding stress biomarkers to high-sensitivity cardiac troponin for rapid non-ST-elevation myocardial infarction rule-out protocolsIngar Ziad Restan, Ana Yufera Sanchez, Ole-Thomas Steiro, et al.
JAMA|July 26, 2017
Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical TrialHans Kirkegaard, Eldar Søreide, Inge de Haas, et al.
American Heart Journal|December 12, 2018
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Vidar Ruddox, Sigrun Halvorsen, et al.
Medicine and Science in Sports and Exercise|November 6, 2019
Baseline and Exercise Predictors of V˙O2peak in Systolic Heart Failure Patients: Results from SMARTEX-HFTrine Karlsen, Vibeke Videm, Martin Halle, et al.
European Journal of Preventive Cardiology|March 14, 2025
Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trialsSophia Marie-Theres Dinges, Edzard Schwedhelm, Julia Schoenfeld, et al.
Pageof 9